HuaNa Pharmaceutical (688799.SH) executives plan to collectively reduce their shareholding by no more than 70,000 shares.

Zhitong Finance APP News, Warner Pharmaceutical (688799.SH) announced that, due to tax payment obligations related to equity incentives and other personal financial needs, certain senior management personnel of the company plan to reduce their directly held company shares through centralized bidding transactions. Among them, Deputy General Manager Xiao Jian plans to reduce no more than 17,500 shares, accounting for no more than 0.0131% of the company's total share capital. Deputy General Manager Zhou Zhigang plans to reduce no more than 17,500 shares, accounting for no more than 0.0131% of the company's total share capital. Board Secretary Qiao Qiao plans to reduce no more than 17,500 shares, accounting for no more than 0.0131% of the company's total share capital. Chief Financial Officer Wu Guiying plans to reduce no more than 17,500 shares, accounting for no more than 0.0131% of the company's total share capital.